Core Laboratories
In David Rolfe's portfolio · Wedgewood Partners
Ticker CLB
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Wedgewood Partners 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2019 | Sell | 0 | |
| Q1 2019 | Reduce 38% | 4,675 | 0.0% |
| Q4 2018 | Reduce 98% | 7,600 | 0.0% |
| Q3 2018 | Reduce 41% | 426,000 | 2.5% |
| Q2 2018 | Reduce 13% | 723,494 | 4.6% |
| Q1 2018 | Reduce 10% | 828,692 | 4.1% |
| Q4 2017 | Reduce 18% | 923,762 | 4.1% |
| Q3 2017 | Reduce 10% | 1,130,193 | 3.8% |
| Q2 2017 | Reduce 20% | 1,262,264 | 3.9% |
| Q1 2017 | Reduce 4% | 1,575,658 | 4.7% |
| Q4 2016 | Reduce 13% | 1,646,324 | 4.8% |
| Q3 2016 | Add 12% | 1,893,080 | 4.5% |
| Q2 2016 | Reduce 14% | 1,687,427 | 4.2% |
| Q1 2016 | Add 1% | 1,953,265 | 4.0% |
| Q4 2015 | Reduce 11% | 1,935,874 | 3.6% |
| Q3 2015 | Reduce 7% | 2,175,190 | 3.2% |
| Q2 2015 | Reduce 7% | 2,349,692 | 3.6% |
| Q1 2015 | Add 14% | 2,528,819 | 3.5% |
| Q4 2014 | Buy | 2,220,875 | 3.6% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.